19 Scopus citations


Current applications of human induced pluripotent stem cell (hiPSC) technologies in patient-specific models of neurodegenerative and neuropsychiatric disorders tend to focus on neuronal phenotypes. Here, we review recent efforts toward advancing hiPSCs toward non-neuronal cell types of the central nervous system (CNS) and highlight their potential use for the development of more complex in vitro models of neurodevelopment and disease. We present evidence from previous works in both rodents and humans of the importance of these cell types (oligodendrocytes, microglia, astrocytes) in neurological disease and highlight new hiPSC-based models that have sought to explore these relationships in vitro. Lastly, we summarize efforts toward conducting high-throughput screening experiments with hiPSCs and propose methods by which new screening platforms could be designed to better capture complex relationships between neural cell populations in health and disease.

Original languageEnglish
Article number117
JournalFrontiers in Cell and Developmental Biology
Issue numberDEC
StatePublished - 19 Dec 2017


  • ALS
  • Drug screening
  • Glia
  • Human induced pluripotent stem cells
  • Rett syndrome
  • Schizophrenia


Dive into the research topics of 'The importance of non-neuronal cell types in hiPSC-based disease modeling and drug screening'. Together they form a unique fingerprint.

Cite this